Study Shows Promise for Expensive Cholesterol Drugs, but They Are Still Hard to Obtain

A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.